Codi QR

Survival Outcomes for Yttrium-90 Transarterial Radioembolization With and Without Sorafenib for Unresectable Hepatocellular Carcinoma Patients

Ajalaya Teyateeti,1,2 Armeen Mahvash,3 James P Long,4 Mohamed E Abdelsalam,3 Rony Avritscher,3 Beth Chasen,1 Ahmed O Kaseb,5 Joshua D Kuban,3 Ravi Murthy,3 Bruno C Odisio,3 Achiraya Teyateeti,6 Homer A Macapinlac,1 S Cheenu Kappadath7 1Department of Nuclear Medicine, Division of Diagnostic Imaging,...

Descripció completa

Guardat en:
Autors principals: Teyateeti A, Mahvash A, Long JP, Abdelsalam ME, Avritscher R, Chasen B, Kaseb AO, Kuban JD, Murthy R, Odisio BC, Macapinlac HA, Kappadath SC
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2020-09-01
Col·lecció:Journal of Hepatocellular Carcinoma
Matèries:
y90
selective internal radiation therapy
therasphere
prognostic factors
adverse events
Accés en línia:https://www.dovepress.com/survival-outcomes-for-yttrium-90-transarterial-radioembolization-with--peer-reviewed-article-JHC
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars